At a glance
ClinicalIndex Comparison RecordN/ACompleted· 41 enrolled
Drug / intervention
TENSdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Noninvasive Electrical Stimulator as an Adjunct for Pain Control After Ureteroscopic Stone Management
In Brief
A clinical study evaluating TENS for Kidney Stone and 2 related conditions. Completed, enrolled 41 participants across 1 site.
Detailed Summary
The investigators will assess the use of Transcutaneous Neurostimulation (TENS), a pharmacological alternative, for treatment of ureteral stent pain post-ureteroscopy. The primary aim for the investigators is to determine if use of a TENS unit will reduce post-operative pain and nausea associated with the ureteral stent. Secondary aim will be to assess if it can help minimize narcotic use.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsKidney Stone, Ureteral Calculi, Nephrolithiasis
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartJan 2021
First PostedDec 2021
Primary CompletionOct 2023
TodayJul 2026
First PostedDec 10, 2021
Enrollment StartJan 10, 2021
Primary CompletionOct 1, 2023
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 4.6 years ago
Interventions
TENSdevice
TENS device used four times a day for 60 minutes each time